154 related articles for article (PubMed ID: 10822083)
1. A new model of allergic rhinitis in rats by topical sensitization and evaluation of H(1)-receptor antagonists.
Sugimoto Y; Kawamoto E; Chen Z; Kamei C
Immunopharmacology; 2000 Jun; 48(1):1-7. PubMed ID: 10822083
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic effects of the histamine H1 receptor antagonist epinastine and the dual thromboxane A2 receptor and chemoattractant receptor-homologous molecule expressed on Th2 cells antagonist ramatroban on allergic rhinitis model in mice.
Suzuki Y; Inoue T; Yamamoto A; Sugimoto Y
Biol Pharm Bull; 2011; 34(4):507-10. PubMed ID: 21467637
[TBL] [Abstract][Full Text] [Related]
3. Validation of guinea pig model of allergic rhinitis by oral and topical drugs.
Bahekar PC; Shah JH; Ayer UB; Mandhane SN; Thennati R
Int Immunopharmacol; 2008 Nov; 8(11):1540-51. PubMed ID: 18627797
[TBL] [Abstract][Full Text] [Related]
4. Participation of chemical mediators other than histamine in nasal allergy signs: a study using mice lacking histamine H(1) receptors.
Kayasuga R; Sugimoto Y; Watanabe T; Kamei C
Eur J Pharmacol; 2002 Aug; 449(3):287-91. PubMed ID: 12167471
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of terfenadine, loratadine, and astemizole in perennial allergic rhinitis.
Crawford WW; Klaustermeyer WB; Lee PH; Placik IM
Otolaryngol Head Neck Surg; 1998 May; 118(5):668-73. PubMed ID: 9591867
[TBL] [Abstract][Full Text] [Related]
6. Effects of TAK-427 on acute nasal symptoms and nasal obstruction in guinea pig model of experimental allergic rhinitis.
Fukuda S; Midoro K; Gyoten M; Kawano Y; Ashida Y; Nabe T; Kohno S; Nagaya H
Eur J Pharmacol; 2003 Aug; 476(3):239-47. PubMed ID: 12969771
[TBL] [Abstract][Full Text] [Related]
7. Effects of fujibitol, a remedy for nasal symptoms, on experimental allergic rhinitis in rats.
Kakimoto M; Sugimoto Y; Harada M; Kobayashi Y; Okuma C; Taga C; Kamei C
Biol Pharm Bull; 2000 Sep; 23(9):1055-8. PubMed ID: 10993204
[TBL] [Abstract][Full Text] [Related]
8. Participation of histamine H3 receptors in experimental allergic rhinitis of mice.
Yokota E; Kuyama S; Sugimoto Y; Ogawa M; Kamei C
J Pharmacol Sci; 2008 Oct; 108(2):206-11. PubMed ID: 18845911
[TBL] [Abstract][Full Text] [Related]
9. Effect of histamine H4 receptor antagonist on allergic rhinitis in mice.
Takahashi Y; Kagawa Y; Izawa K; Ono R; Akagi M; Kamei C
Int Immunopharmacol; 2009 Jun; 9(6):734-8. PubMed ID: 19275949
[TBL] [Abstract][Full Text] [Related]
10. Allergic rhinitis model with Brown Norway rat and evaluation of antiallergic drugs.
Takahashi N; Aramaki Y; Tsuchiya S
J Pharmacobiodyn; 1990 Jul; 13(7):414-20. PubMed ID: 1705288
[TBL] [Abstract][Full Text] [Related]
11. Substance P is involved in the effect of histamine H3 receptor agonist, Sch 50971 on nasal allergic symptoms in mice.
Yokota E; Kuyama S; Ogawa M; Kamei C
Int Immunopharmacol; 2008 Aug; 8(8):1083-8. PubMed ID: 18550011
[TBL] [Abstract][Full Text] [Related]
12. Effect of 5-aminosalicylate on allergic rhinitis model in mice.
Kuyama S; Yamamoto A; Sugiyama M; Kakuta H; Sugimoto Y
Int Immunopharmacol; 2010 Jun; 10(6):713-6. PubMed ID: 20304104
[TBL] [Abstract][Full Text] [Related]
13. Effects of mometasone furoate on a rat allergic rhinitis model.
Tsumuro T; Ogawa M; Minami K; Takubo M; Rahman A; Fujii Y; Kamei C
Eur J Pharmacol; 2005 Nov; 524(1-3):155-8. PubMed ID: 16256103
[TBL] [Abstract][Full Text] [Related]
14. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells.
Jie Q; Kodithuwakku ND; Yuan X; He G; Chen M; Xu S; Wu Y
Eur J Pharmacol; 2015 May; 754():1-10. PubMed ID: 25704613
[TBL] [Abstract][Full Text] [Related]
15. Interactive effect of histamine and prostaglandin D2 on nasal allergic symptoms in rats.
Rahman A; Inoue T; Ago J; Ishikawa T; Kamei C
Eur J Pharmacol; 2007 Jan; 554(2-3):229-34. PubMed ID: 17112500
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of the clinical efficacy and safety of epinastine plus pseudoephedrine vs loratadine plus pseudoephedrine in perennial allergic rhinitis].
Hernández Colín D; González Díaz SN; Rodríguez Medina R; Aguilar Angeles D; González Gámez J; Becerril Angeles M; Orea Solano M; Domínguez Henkel R; Segovia Ayala C
Rev Alerg Mex; 2004; 51(1):23-8. PubMed ID: 15119752
[TBL] [Abstract][Full Text] [Related]
17. Effect of mometasone furoate by topical application on allergic rhinitis model in rats.
Sugimoto Y; Ishizawa K; Saitou K; Suzuki G; Tarumi T; Nakahara H; Kirino Y; Kamei C
Pharmacology; 2000 Aug; 61(2):91-5. PubMed ID: 10940782
[TBL] [Abstract][Full Text] [Related]
18. Involvement of chemical mediators in nasal allergic responses of HDC-KO mice.
Rahman MA; Inoue T; Ishikawa T; Yatsuzuka R; Ohtsu H; Kamei C
Eur J Pharmacol; 2007 Jul; 567(3):245-51. PubMed ID: 17543300
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy of KOB03, ketotifen, and montelukast in an experimental mouse model of allergic rhinitis.
Jung HW; Jung JK; Park YK
Int Immunopharmacol; 2013 Jun; 16(2):254-60. PubMed ID: 23643816
[TBL] [Abstract][Full Text] [Related]
20. Establishment of an allergic rhinitis model in mice for the evaluation of nasal symptoms.
Tsunematsu M; Yamaji T; Kozutsumi D; Murakami R; Kimura S; Kino K
Life Sci; 2007 Mar; 80(15):1388-94. PubMed ID: 17300813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
